Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Equity Income (2016 - 2024)

Historic Equity Income for Bristol Myers Squibb (BMYMP) over the last 15 years, with Q3 2024 value amounting to -$23.0 million.

  • Bristol Myers Squibb's Equity Income fell 22777.78% to -$23.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $12.0 million, marking a year-over-year decrease of 8441.56%. This contributed to the annual value of -$4.0 million for FY2019, which is 10430.11% down from last year.
  • As of Q3 2024, Bristol Myers Squibb's Equity Income stood at -$23.0 million, which was down 22777.78% from $28.0 million recorded in Q2 2024.
  • In the past 5 years, Bristol Myers Squibb's Equity Income ranged from a high of $40.0 million in Q3 2021 and a low of -$23.0 million during Q3 2024
  • Moreover, its 4-year median value for Equity Income was $23.0 million (2023), whereas its average is $13.7 million.
  • Data for Bristol Myers Squibb's Equity Income shows a peak YoY increase of 35454.55% (in 2024) and a maximum YoY decrease of 22777.78% (in 2024) over the last 5 years.
  • Quarter analysis of 4 years shows Bristol Myers Squibb's Equity Income stood at $30.0 million in 2020, then surged by 33.33% to $40.0 million in 2021, then crashed by 55.0% to $18.0 million in 2023, then crashed by 227.78% to -$23.0 million in 2024.
  • Its Equity Income stands at -$23.0 million for Q3 2024, versus $28.0 million for Q2 2024 and $18.0 million for Q3 2023.